Press releaseBusiness Wire
NU Skin Enterprises
NUS · NYSE
$4.98+$0.01 (+0.20%)TodayMarket closed ·
Prev close $4.97
Latest news
- News
Nu Skin Enterprises Q2 Adj. EPS $0.20, Inline, Sales $320.112M Miss $345.200M Estimate
- Press releaseBusiness Wire
Nu Skin Enterprises Reports Second Quarter Results
- Press releaseBusiness Wire
Nu Skin Enterprises Announces Quarterly Dividend
- Press releaseBusiness Wire
Nu Skin Enterprises to Announce Second Quarter 2026 Financial Results
- Press releaseBusiness Wire
Nu Skin Reaches 900 Million Meals Purchased and Donated in its Global Fight for Child Nutrition
- News
Nu Skin Enterprises Q1 Adj. EPS $0.14 Misses $0.15 Estimate, Sales $320.600M Miss $329.700M Estimate
- Press releaseBusiness Wire
Nu Skin Enterprises Reports First Quarter Results
- Press releaseBusiness Wire
Nu Skin Enterprises Announces Quarterly Dividend
- Press releaseBusiness Wire
Nu Skin Enterprises to Announce First Quarter 2026 Financial Results
- Press releaseBusiness Wire
Nu Skin Launches Prysm iO™: A Revolutionary AI-Powered Platform for Personalized Nutritional Wellness
- Press releaseBusiness Wire
Nu Skin Enterprises Appoints Chelsea Lantz as Interim Chief Financial Officer
- Press releaseBusiness Wire
Nu Skin Appoints Chayce Clark as COO
- NewsAvi Kapoor
Pinterest Posts Downbeat Results, Joins DraftKings, Toast, Expedia And Other Big Stocks Moving Lower In Friday's Pre-Market Session
- NewsAvi Kapoor
Top 3 Defensive Stocks That May Rocket Higher In February
- NewsAkanksha Bakshi
Nu Skin Stock Sinks After Weak Quarter, Soft Outlook
- News
Nu Skin Enterprises Q4 EPS $0.29 Misses $0.30 Estimate, Sales $370.320M Miss $382.700M Estimate
- Press releaseBusiness Wire
Nu Skin Enterprises Reports Fourth Quarter and Full-year 2025 Results Within Guidance
- Press releaseBusiness Wire
Nu Skin Enterprises Announces Quarterly Dividend
- News
Earnings Scheduled For February 12, 2026
- Press releaseBusiness Wire
Dr. Joseph Chang Launches Update to Bestselling Book "The Aging Myth" With 15 More Years of Breakthrough Research on Cellular Wellness
- News
5 Undervalued Safe-Haven Stocks with Strong Dividends
- Press releaseBusiness Wire
Nu Skin Enterprises to Announce Fourth Quarter and Full Year 2025 Financial Results
- Press releaseBusiness Wire
Nu Skin Enterprises to Discuss Company Strategy and Opportunities at ICR Conference
- Press releaseBusiness Wire
Nu Skin Releases 2024 Social Impact and Sustainability Report
- Press releaseBusiness Wire
Nu Skin Unveils Prysm iO™: An Evolution in Intelligent Nutritional Wellness
- Press releaseBusiness Wire
Nu Skin Enterprises Reports Third Quarter Earnings
- Press releaseBusiness Wire
Nu Skin Enterprises Announces Quarterly Dividend
- News
Earnings Scheduled For November 6, 2025
- Press releaseBusiness Wire
Nu Skin Enterprises to Announce Third Quarter 2025 Financial Results
- Press releaseBusiness Wire
Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Second Consecutive Year
- Press releaseBusiness Wire
Nu Skin Enterprises Reports Second Quarter Revenue at High End of Guidance and Earnings Per Share Above Guidance
- Press releaseBusiness Wire
Nu Skin Enterprises Announces Quarterly Dividend
- Press releaseBusiness Wire
Nu Skin Enterprises to Announce Second Quarter 2025 Financial Results
- Press releaseBusiness Wire
Nu Skin Enterprises Reports First Quarter Revenue at High End of Guidance
- News
Earnings Scheduled For May 8, 2025
- NewsAvi Kapoor
Nasdaq Surges Above 20,000; Crude Oil Moves Lower
- NewsAvi Kapoor
Dow Falls 100 Points; US Industrial Output Increases In January
- Press releaseBusiness Wire
Nu Skin Enterprises Reports Fourth Quarter and Full-year 2024 Results Above Company Revenue Guidance
- Press releaseBusiness Wire
Nu Skin Enterprises Announces Strategic Transaction of Mavely for $250 Million
- Press releaseBusiness Wire
Nu Skin Enterprises Reports Third Quarter Results
- Press releaseBusiness Wire
Nu Skin Enterprises Reports Second Quarter Results
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.